Tarka tablets with mod. release p / o 240 + 4mg, No. 28

Essential arterial hypertension (for patients for whom combination therapy is indicated).

known hypersensitivity to any component of the drug or to any other ACE inhibitor, including a history of angioedema associated with treatment with ACE inhibitors;

cardiogenic shock;

chronic heart failure stage IIB and III;

simultaneous reception of beta-blockers;

AV block II Ц III degree (except for patients with an artificial pacemaker);

acute myocardial infarction;

sick sinus syndrome (except for patients with an artificial pacemaker);

acute heart failure;

atrial fibrillation / flutter;

WPW and Laun-Ganong-Levin syndrome;

severe bradycardia;

severe arterial hypotension;

impaired renal function (Cl creatinine <30 ml / min);

pregnancy;

breastfeeding period;

age up to 18 years (efficacy and safety have not been established).

Carefully:

aortic stenosis;

hypertrophic obstructive cardiomyopathy;

impaired liver and / or kidney function;

systemic connective tissue diseases (including systemic lupus erythematosus, scleroderma);

oppression of bone marrow hematopoiesis;

AV blockade of the 1st degree;

bradycardia;

arterial hypotension;

a condition accompanied by a decrease in the BCC (including diarrhea, vomiting);

bilateral renal artery stenosis;

stenosis of an artery of a single kidney;

condition after kidney transplantation;

in patients on a salt-restricted diet who are on hemodialysis;

combined use with diuretics.